Skip to main content

About
Products
Clinical
Investors
Contact
- - Back
  - Contact Us
Sign Up
Language
- - Back
  - GER

adobe stock 229690447 preview

NEWS
2022

2023
2022
2021

List of articles in category 2022 News
Title
05.01.2022 Marizyme Announces Allowance of Patent Application for Flagship Product DuraGraft by United States Patent and Trademark Office

imgfooter

Marizyme, Inc. is a multi-technology biomedical company dedicated to the accelerated development and commercialization of medical technologies that improve patient health outcomes.

Investors

Back
Stock Info
SEC Filings
Corporate Governance

Contact

Back
Contact Us
Sign Up

	Get In Touch
	555 Heritage Drive, Ste. 205, Jupiter, FL 33458
	(561) 935-9955
	info@marizyme.com

© Copyright - 2023 Marizyme Inc. | All Rights Reserved | Website by Sandman Media Inc